pe
pep-05227 v1 CC-BY-SA-4.0

Defensin beta 136 anticancer peptide

A peptide studied in the lab for its ability to fight cancer cells; experimental, not yet an approved drug.

statusbioassayed targetANTICANCER length57 aa refs3
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.347
avg pLDDT46.6
ranking score0.443
STRUCTURE · PEP-05227 × ANTICANCER
ranking0.443
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence57 aa
151015202530354045505557
MFGNDGVKVRTCTSQKAVC FFGCPPGYRWIAFCHNILS CCKNMTRFQPLQAKDPWVH
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.44254931807518005 boltz-2
3-letter notation
Met-Phe-Gly-Asn-Asp-Gly-Val-Lys-Val-Arg-Thr-Cys-Thr-Ser-Gln-Lys-Ala-Val-Cys-Phe-Phe-Gly-Cys-Pro-Pro-Gly-Tyr-Arg-Trp-Ile-Ala-Phe-Cys-His-Asn-Ile-Leu-Ser-Cys-Cys-Lys-Asn-Met-Thr-Arg-Phe-Gln-Pro-Leu-Gln-Ala-Lys-Asp-Pro-Trp-Val-His
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Defensin beta 136 anticancer peptide (pep-05227, v1). PeptideModel. https://peptidemodel.com/card/pep-05227
@peptide{pep05227,
  sequence = {MFGNDGVKVRTCTSQKAVCFFGCPPGYRWIAFCHNILSCCKNMTRFQPLQAKDPWVH},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use